Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1 beta-mediated colitis
  2. Mao, Liming; Kitani, Atsushi; Hiejima, Eitaro; Montgomery-Recht,Kim; Zhou, Wenchang; Fuss, Ivan; Wiestner, Adrian; Strober, Warren
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, Apr 1; 130(4): 1793-1807.
  1. 2.   Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia
  2. McMaster, Mary L.; Berndt, Sonja; Zhang, Jianqing; Slager, Susan L.; Li,Shengchao; Vajdic, Claire M.; Smedby, Karin E.; Yan, Huihuang; Birmann, Brenda M.; Brown, Elizabeth E.; Smith, Alex; Kleinstern, Geffen; Fansler, Mervin M.; Mayr, Christine; Zhu,Bin; Chung,Charles; Park, Ju-Hyun; Burdette, Laurie; Hicks,Belynda; Hutchinson,Amy; Teras, Lauren R.; Adami, Hans-Olov; Bracci, Paige M.; McKay, James; Monnereau, Alain; Link, Brian K.; Vermeulen, Roel C. H.; Ansell, Stephen M.; Maria, Ann; Diver, W. Ryan; Melbye, Mads; Ojesina, Akinyemi; Kraft, Peter; Boffetta, Paolo; Clavel, Jacqueline; Giovannucci, Edward; Besson, Caroline M.; Canzia, Federico; Travis, Ruth C.; Vineis, Paolo; Weiderpass, Elisabete; Montalvan, Rebecca; Wang, Zhaoming; Yeager,Meredith; Becker, Nikolaus; Benavente, Yolanda; Brennan, Paul; Foretova, Lenka; Maynadie, Marc; Nieters, Alexandra; de Sanjose, Silvia; Staines, Anthony; Conde, Lucia; Riby, Jacques; Glimelius, Bengt; Hjalgrim, Henrik; Pradhan, Nisha; Feldman, Andrew L.; Novak, Anne J.; Lawrence, Charles; Bassig, Bryan A.; Lan, Qing; Zheng, Tongzhang; North, Kari E.; Tinker, Lesley F.; Cozen, Wendy; Severson, Richard K.; Hofmann, Jonathan N.; Zhang, Yawei; Jackson, Rebecca D.; Morton, Lindsay M.; Purdue, Mark P.; Chatterjee, Nilanjan; Offit, Kenneth; Cerhan, James R.; Chanock, Stephen J.; Rothman, Nathaniel; Vijai, Joseph; Goldin, Lynn R.; Skibola, Christine F.; Caporaso, Neil E.
  3. NATURE COMMUNICATIONS. 2018, OCT 10; 9(1): 4182.
  1. 3.   Evolution of multiple cell clones over a 29-year period of a CLL patient
  2. Zhao, Zhikun; Goldin, Lynn; Liu, Shiping; Wu, Liang; Zhou, Weiyin; Lou, Hong; Yu, Qichao; Tsang, Shirley X.; Jiang, Miaomiao; Li, Fuqiang; McMaster, MaryLou; Li, Yang; Lin, Xinxin; Wang, Zhifeng; Xu, Liqin; Marti, Gerald; Li, Guibo; Wu, Kui; Yeager, Meredith; Yang, Huanming; Xu, Xun; Chanock, Stephen J.; Li, Bo; Hou, Yong; Caporaso, Neil; Dean, Michael
  3. NATURE COMMUNICATIONS. 2016, Dec 16; 7: 13765.
  1. 4.   Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma
  2. Bassig, B. A.; Zheng, T. Z.; Zhang, Y. W.; Berndt, S. I.; Holford, T. R.; Hosgood, H. D.; Hu, W.; Leaderer, B.; Yeager, M.; Menashe, I.; Boyle, P.; Xu, J.; Zou, K. Y.; Zhu, Y.; Chanock, S.; Rothman, N.; Lan, Q.
  3. Environmental and Molecular Mutagenesis. 2012, Mar; 53(2): 145-151.
  1. 5.   Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen
  2. Rahrmann, E. P.; Collier, L. S.; Knutson, T. P.; Doyal, M. E.; Kuslak, S. L.; Green, L. E.; Malinowski, R. L.; Roethe, L.; Akagi, K.; Waknitz, M.; Huang, W.; Largaespada, D. A.; Marker, P. C.
  3. Cancer Research. 2009 69(10): 4388-4397.
  1. 6.   microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies
  2. Wei, J. S.; Johansson, P.; Chen, Q. R.; Song, Y. K.; Durinck, S.; Wen, X. Y.; Cheuk, A.; Smith, M. A.; Houghton, P.; Morton, C.; Khan, J.
  3. Clinical Cancer Research. 2009 15(17): 5560-5568.
  1. 7.   The identification of microRNAs in a genomically unstable region of human chromosome 8q24
  2. Huppi, K.; Volfovsky, N.; Runfola, T.; Jones, T. L.; Macklewicz, M.; Martin, S. E.; Mushinski, J. F.; Stephens, R.; Caplen, N. J.
  3. Molecular Cancer Research. 2008 6(2): 212-221.
  1. 8.   CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors
  2. Baatar, D.; Olkhanud, P.; Newton, D.; Sumitomo, K.; Biragyn, A.
  3. Journal of Immunology. 2007, Aug; 179(3): 1996-2004.
  1. 9.   MicroRNAs and genomic instability
  2. Huppi, K.; Volfovsky, N.; Mackiewicz, M.; Runfola, T.; Jones, T. L.; Martin, S. E.; Stephens, R.; Caplen, N. J.
  3. Seminars in Cancer Biology. 2007, Feb; 17(1): 65-73.
  1. 10.   Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis
  2. Timofeeva, O. A.; Plisov, S.; Evseev, A. A.; Peng, S.; Jose-Kampfner, M.; Lovvorn, H. N.; Dome, J. S.; Perantoni, A. O.
  3. Oncogene. 2006, Dec; 25(58): 7555-7564.
  1. 11.   Selective leukemic-cell killing by a novel functional class of thalidomide analogs
  2. Ge, Y.; Montano, I.; Rustici, G.; Freebern, W. J.; Haggerty, C. M.; Cui, W. W.; Ponciano-Jackson, D.; Chandramouli, G. V. R.; Gardner, E. R.; Figg, W. D.; Abu-Asab, M.; Tsokos, M.; Jackson, S. H.; Gardner, K.
  3. Blood. 2006, Dec; 108(13): 4126-4135.
  1. 12.   An expanding appreciation of the role chemokine receptors play in cancer progression
  2. Howard, O. M. Z.; Galligan, C. L.
  3. Current Pharmaceutical Design. 2004 10(19): 2377-2389.
  1. 13.   ATM mutations and protein expression are not associated with familial B-CLL cases
  2. Ishibe, N.; Goldin, L. R.; Caporaso, N. E.; Sgambati, M. T.; Dean, M.; Albitar, M.; Manshouri, T.; Gerrard, B.; Marti, G. E.
  3. Leukemia Research. 2003 27(10): 973-975.
  1. 14.   Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
  2. Tan, A. R.; Headlee, D.; Messmann, R.; Sausville, E. A.; Arbuck, S. G.; Murgo, A. J.; Melillo, G.; Zhai, S. P.; Figg, W. D.; Swain, S. M.; Senderowicz, A. M.
  3. Journal of Clinical Oncology. 2002 20(19): 4074-4082.
  1. 15.   Erf - Genomic Organization, Chromosomal Localization and Promoter Analysis of the Human and Mouse Genes
  2. Liu, D. R.; Pavlopoulos, E.; Modi, W.; Moschonas, N.; Mavrothalassitis, G.
  3. Oncogene. 1997 14(12): 1445-1451.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel